Investitionsbank des Landes Brandenburg

Dryad Networks is a developer of Internet of Things technology that aims to avert wildfire catastrophe. The company's technology creates a large-scale IoT network that enables public and private forest owners to monitor, analyze, and safeguard the world's largest and most remote woods, allowing the forest department to spot wildfires early on.

SageWealth provides a range of investing options focusing on sustainability, including growth-focused equity-based and safety-focused bond and commodity-based options.

ScaleHub, a Managed Service Hub for AI data labeling and data processing best practices delivers super-human quality data - at scale. ScaleHub's solution is HIPAA compliant, ISO 27001:2013 certified and GdPR compliant.

Using cutting edge artificial intelligence (AI) technology, Oculyze has created computer vision software that automates tedious manual image analysis and speeds up lab work. This revolutionary approach was proven to be successful with the launching of the automated yeast cell counters & apps for breweries and wineries: • Oculyze BB 2.0 (Better Brewing) Yeast Cell Counter App • Oculyze FW (Fermentation Wine) Yeast Cell Counter App The Oculyze yeast cell counting kit works by using a microscope connected to a smartphone or tablet and the Oculyze app. The images are then uploaded to the cloud where they are analyzed by image recognition algorithms, offering quantitative real-time image analysis. Breweries and wineries of all sizes around the world have now chosen to replace the time-consuming and human error - prone standard method (yeast cell count using haemocytometer) with Oculyze, a far more reliable, fast, and cost-saving solution for monitoring fermentation during all the stages of the production process. While working on constantly improving its flagship products, Oculyze also focuses on bringing the advantages of cloud-based image recognition, like faster development time, lower cost and better image recognition to other applications such as ethanol and bioethanol (or ethanol fuel) production, blood or sperm counts, parasite detection in feces, asbestos fiber detection, emulsion analysis, and bacteria detection, thereby continuing to add applications to its cloud-based image recognition platform. Oculyze can offer turnkey solutions to businesses, integrating three essential components – the image analysis platform (for data storage & backup, user authentication, and task handling), a custom image analysis & recognition software and the image capture software developed by Oculyze. Alternatively, owing to the open nature of Oculyze’s API, its image recognition software can be fully integrated into existing software, improving on the solutions that already work.

Emperra E-Health Technologies develops GSM and web based Tele-medical products for tracking, monitoring, and transmission of diagnostic and therapeutic data of diabetic patients such as insulin doses, blood sugar levels and carbohydrates. The company was founded in 2008 and is based in Potsdam, Germany.

Clipnow creates virtual 360° real estate rounds as well as spoken, automated videos for website and portals.

EBS Technologies is a medical device company that has developed a stimulation system for the treatment of neurologically caused impairments such as visual field loss. Such impairments can be the result of stroke, traumatic-brain-injury, glaucoma or several other diseases. The EBS Therapy (previously: NEXT WAVE™Therapy) is a non-invasive optic nerve stimulation deploying weak electrical currents, resulting in neuroregeneration and neuroprotection. Low-voltage electrical pulses are administered at frequencies and amplitudes identified as optimal for each patient, allowing retinal ganglion cells to regenerate and branch out new axons. The company benefits from more than 15 years of research and clinical experience with more than 1,200 patients. Double blind, randomized studies, as well as clinical observations show that the EBS Therapy can partially restore vision field in patients. In 2013 EBS Technologies received the CE Mark for the stimulation device and started the commercial treatment in 2014. There are currently 8 EBS Treatment centers across Germany and the company is slowly widening the network.